Regulatory approval for new antihumoral therapies: addressing the barriers
- PMID: 21521463
- DOI: 10.1111/j.1600-6143.2011.03526.x
Regulatory approval for new antihumoral therapies: addressing the barriers
Comment on
-
Summary of FDA antibody-mediated rejection workshop.Am J Transplant. 2011 May;11(5):896-906. doi: 10.1111/j.1600-6143.2011.03525.x. Am J Transplant. 2011. PMID: 21521465
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
